Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

MLA

Bock, Peter, et al. “Attrition When Providing Antiretroviral Treatment at CD4 Counts >500cells/ΜL at Three Government Clinics Included in the HPTN 071 (PopART) Trial in South Africa.” PLoS ONE, vol. 13, no. 3, Apr. 2018, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0195127.

APA

Bock, P., Fatti, G., Ford, N., Jennings, K., Kruger, J., Gunst, C., Louis, F., Grobbelaar, N., Shanaube, K., Floyd, S., Grimwood, A., Hayes, R., Ayles, H., Fidler, S., Beyers, N., & null, null. (2018). Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa. PLoS ONE, 13(3), 1–12. https://doi.org/10.1371/journal.pone.0195127

Chicago

Bock, Peter, Geoffrey Fatti, Nathan Ford, Karen Jennings, James Kruger, Colette Gunst, Françoise Louis, et al. 2018. “Attrition When Providing Antiretroviral Treatment at CD4 Counts >500cells/ΜL at Three Government Clinics Included in the HPTN 071 (PopART) Trial in South Africa.” PLoS ONE 13 (3): 1–12. doi:10.1371/journal.pone.0195127.